Abstract

The burden of fungal infections on human health is increasing worldwide. Aspergillus, Candida, and Cryptococcus are the top three human pathogenic fungi that are responsible for over 90% of infection-related deaths. Moreover, effective antifungal therapeutics are lacking, primarily due to host toxicity, pathogen resistance, and immunodeficiency. In recent years, nanomaterials have proved not only to be more efficient antifungal therapeutic agents but also to overcome resistance against fungal medication. This review will examine the limitations of standard antifungal therapy as well as focus on the development of nanomaterials.

Details

Title
Progress in the application of nanoparticles for the treatment of fungal infections: A review
Author
Zhu, Xinlin 1 ; Chen, Youming 2 ; Yu, Dan 3 ; Fang, Wenjie 1 ; Liao, Wanqing 1 ; Pan, Weihua 1 

 Department of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Second Affiliated Hospital of Naval Medical University, Shanghai, China 
 Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China 
 Department of General Practice, Second Affiliated Hospital of Naval Medical University, Shanghai, China 
Pages
1-16
Publication year
2024
Publication date
Mar 2024
Publisher
Taylor & Francis Ltd.
ISSN
21501203
e-ISSN
21501211
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3092108343
Copyright
© 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.